Methodological differences account for inconsistencies in reported free VEGF concentrations in pregnant rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 306, Issue 11, 2014, Pages

  Weissgerber, Tracey L ^a   McConico, Andrea ^a   Knudsen, Bruce E ^a   Butters, Kim A ^a   Hayman, Suzanne R ^a   White, Wendy M ^a   Milic, Natasa ^a,b   Miller, Virginia M ^c   Garovic, Vesna D ^a  

^a MAYO CLINIC   (United States)

^b CLINICAL CENTER OF SERBIA   (Serbia)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Heparin; Preeclampsia; Pregnancy; sFLT 1; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; NONHUMAN; PLASMA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RAT;

HEPARIN; PREECLAMPSIA; PREGNANCY; SFLT-1; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MICE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84902660978     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00544.2013     Document Type: Article

References (31)

1. Annonymous. Reproducing our irreproducibility. Nature 496: 398, 2013.
2. Agunanne EE, Uddin MN, Horvat D, Puschett JB. Contribution of angiogenic factors in a rat model of pre-eclampsia. Am J Nephrol 32: 332-339, 2010.
3. Bahtiyar MO, Buhimschi C, Ravishankar V, Copel J, Norwitz E, Julien S, Guller S, Buhimschi IA. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction. Am J Obstet Gynecol 196: 72 e71-e76, 2007.
4. Banek CT, Bauer AJ, Gingery A, Gilbert JS. Timing of ischemic insult alters fetal growth trajectory, maternal angiogenic balance, and markers of renal oxidative stress in the pregnant rat. Am J Physiol Regul Integr Comp Physiol 303: R658-R664, 2012.
5. Banek CT, Bauer AJ, Needham KM, Dreyer HC, Gilbert JS. AICAR administration ameliorates hypertension and angiogenic imbalance in a model of preeclampsia in the rat. Am J Physiol Heart Circ Physiol 304: H1159-H1165, 2013.
6. Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, Kaufmann S, Walters CE, Jackson A, Eves P, Linton G, Keen J, Walker JJ, Selby PJ. Evidence for the existence of a novel pregnancyassociated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod 4: 377-386, 1998.
7. Bauer AJ, Banek CT, Needham K, Gillham H, Capoccia S, Regal JF, Gilbert JS. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension. Hypertension 61: 1103-1110, 2013.
8. Bridges JP, Gilbert JS, Colson D, Gilbert SA, Dukes MP, Ryan MJ, Granger JP. Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats. Am J Hypertens 22: 564-568, 2009.
9. Daniel W. Biostatistics: A Foundation for Analysis in the Health Sciences. New York: Wiley, 2009.
10. George EM, Arany M, Cockrell K, Storm MV, Stec DE, Granger JP. Induction of heme oxygenase-1 attenuates sFlt-1-induced hypertension in pregnant rats. Am J Physiol Regul Integr Comp Physiol 301: R1495-R1500, 2011.
11. George EM, Cockrell K, Adair TH, Granger JP. Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol 299: R1629-R1633, 2010.
12. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57: 941-948, 2011.
13. George EM, Hosick PA, Stec DE, Granger JP. Heme oxygenase inhibition increases blood pressure in pregnant rats. Am J Hypertens 26: 924-930, 2013.
14. George EM, Palei AC, Dent EA, Granger JP. Sildenafil attenuates placental ischemia-induced hypertension. Am J Physiol Regul Integr Comp Physiol 305: R397-R403, 2013.
15. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50: 1142-1147, 2007.
16. Gilbert JS, Banek CT, Bauer AJ, Gingery A, Dreyer HC. Placental and vascular adaptations to exercise training before and during pregnancy in the rat. Am J Physiol Regul Integr Comp Physiol 303: R520-R526, 2012.
17. Gilbert JS, Banek CT, Bauer AJ, Gingery A, Needham K. Exercise training attenuates placental ischemia-induced hypertension and angiogenic imbalance in the rat. Hypertension 60: 1545-1551, 2012.
18. Gilbert JS, Verzwyvelt J, Colson D, Arany M, Karumanchi SA, Granger JP. Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemiainduced hypertension. Hypertension 55: 380-385, 2010.
19. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47: 617-623, 2001.
20. Kapur NK, Shenoy C, Yunis AA, Mohammad NN, Wilson S, Paruchuri V, Mackey EE, Qiao X, Shah A, Esposito ML, Karas RH, Jaffe IZ. Distinct effects of unfractionated heparin versus bivalirudin on circulating angiogenic peptides. PLos One 7: e34344, 2012.
21. Lillegard KE, Johnson AC, Lojovich SJ, Bauer AJ, Marsh HC, Gilbert JS, Regal JF. Complement activation is critical for placental ischemia-induced hypertension in the rat. Mol Immunol 56: 91-97, 2013.
22. Mann P. Introductory Statistics. New York: Wiley, 2009.
23. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658, 2003.
24. Ramesar SV, Mackraj I, Gathiram P, Moodley J. Sildenafil citrate decreases sFlt-1 and sEng in pregnant L-NAME treated Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol 157: 136-140, 2011.
25. Spradley FT, Palei AC, Granger JP. Obese melanocortin-4 receptordeficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy. Physiol Rep 1: e00081, 2013.
26. Tissot van Patot MC, Leadbetter G, Keyes LE, Bendrick-Peart J, Beckey VE, Christians U, Hackett P. Greater free plasma VEGF and lower soluble VEGF receptor-1 in acute mountain sickness. J Appl Physiol (1985) 98: 1626-1629, 2005.
27. Wadman M. NIH mulls rules for validating key results. Nature 500: 14-16, 2013.
28. Weissgerber TL, Davies GA, Roberts JM. Modification of angiogenic factors by regular and acute exercise during pregnancy. J Appl Physiol 108: 1217-1223, 2010.
29. Weissgerber TL, Rajakumar A, Myerski AC, Edmunds LR, Powers RW, Roberts JM, Gandley RE, Hubel CA. Vascular pool of releasable soluble VEGF receptor-1 (sFLT1) in women with previous preeclampsia and uncomplicated pregnancy. J Clin Endocrinol Metab: jc20133277, 2013.
30. Woods AK, Hoffmann DS, Weydert CJ, Butler SD, Zhou Y, Sharma RV, Davisson RL. Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice. Hypertension 57: 94-102, 2011.
31. Zamudio S, Kovalenko O, Echalar L, Torricos T, Al-Khan A, Alvarez M, Illsley NP. Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy. Placenta 34: 1170-1176, 2013.